SNGX · NASDAQ
Soligenix (SNGX) Stock Price & Fundamentals
Soligenix (SNGX) closed at $701.95 on Oct 9, 2026, down 0.80% from the previous close of $707.62.
Share price, past year
1Y +38.44%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $701.95 |
| Sep 30, 2026 | $682.93 |
| Aug 31, 2026 | $600.65 |
| Jul 31, 2026 | $573.72 |
| Jun 30, 2026 | $573.34 |
| May 29, 2026 | $570.22 |
| Apr 30, 2026 | $571.42 |
| Mar 31, 2026 | $561.50 |
| Feb 27, 2026 | $547.50 |
| Jan 30, 2026 | $543.71 |
| Dec 31, 2025 | $564.28 |
| Nov 28, 2025 | $528.26 |
| Oct 31, 2025 | $534.34 |
Key statistics
- Market cap
- $15.19B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.75
- Revenue (TTM)
- —
- Net income (TTM)
- −$10.24M
- Shares outstanding
- 21.6M
- Dividend yield
- —
- 52-week range
- $507.06 – $710.27
Soligenix's market cap is $15.19B, based on a share price of $701.95 and 21.6M shares outstanding as of Jun 30, 2026.
Financials
Soligenix reported revenue of $119.37K for fiscal 2024, down 85.78% from fiscal 2023.
Soligenix reported a net loss of $11.08M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $119.37K | −85.8% | −$8.27M | −6,925.1% | −$4.98 | — |
| FY2023ended Dec 31, 2023 | $839.36K | −11.6% | −$6.14M | −731.6% | −$12.66 | — |
| FY2022ended Dec 31, 2022 | $948.91K | +15.1% | −$13.80M | −1,454.1% | −$76.96 | — |
| FY2021ended Dec 31, 2021 | $824.27K | −65.1% | −$12.55M | −1,522.7% | −$75.04 | — |
| FY2020ended Dec 31, 2020 | $2.36M | −49.0% | −$17.69M | −749.7% | −$152.84 | — |
| FY2019ended Dec 31, 2019 | $4.63M | −11.7% | −$9.36M | −202.1% | −$114.63 | — |
| FY2018ended Dec 31, 2018 | $5.24M | −3.5% | −$8.90M | −169.8% | −$162.39 | — |
| FY2017ended Dec 31, 2017 | $5.43M | −48.0% | −$7.15M | −131.6% | −$277.01 | — |
| FY2016ended Dec 31, 2016 | $10.45M | +19.2% | −$3.25M | −31.1% | −$320.00 | — |
| FY2015ended Dec 31, 2015 | $8.77M | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2024ended Jun 30, 2024 | $2.34K | — | — |
| Q1 FY2024ended Mar 31, 2024 | $117.03K | — | — |
| Q4 FY2023ended Dec 31, 2023 | $244.81K | — | — |
| Q3 FY2023ended Sep 30, 2023 | $130.44K | — | — |
| Q2 FY2023ended Jun 30, 2023 | $206.93K | — | — |
| Q1 FY2023ended Mar 31, 2023 | $257.18K | — | — |
| Q4 FY2022ended Dec 31, 2022 | $366.07K | — | — |
| Q3 FY2022ended Sep 30, 2022 | $166.14K | — | — |
Company profile
- Name
- Soligenix, Inc.
- Ticker
- SNGX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 29 Emmons Drive, Suite B-10, Princeton, NJ 08540
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000812796
Recent SEC filings
- Sep 21, 2026
- Aug 7, 2026
- Jun 26, 2026
- Jun 12, 2026
- May 28, 2026
- May 8, 2026
- Apr 28, 2026
- Mar 31, 2026
Frequently asked questions
What is Soligenix's stock price?
Soligenix (SNGX) closed at $701.95 on Oct 9, 2026, down 0.80% from the previous close of $707.62.
What is Soligenix's market cap?
Soligenix's market cap is $15.19B, based on a share price of $701.95 and 21.6M shares outstanding as of Jun 30, 2026.
How much revenue does Soligenix make?
Soligenix reported revenue of $119.37K for fiscal 2024, down 85.78% from fiscal 2023.
Does Soligenix pay a dividend?
Soligenix's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Soligenix, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures